Biogipuzkoa
Centro de investigación
Hospital de Clínicas de Porto Alegre
Porto Alegre, BrasilPublicaciones en colaboración con investigadores/as de Hospital de Clínicas de Porto Alegre (9)
2023
-
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
The Lancet Oncology, Vol. 24, Núm. 12, pp. e461-e471
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
2022
-
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
The Lancet Oncology, Vol. 23, Núm. 9, pp. 1145-1155
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
eLife, Vol. 10
2019
2017
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367
-
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
The Lancet, Vol. 390, Núm. 10113, pp. 2627-2642
2011
-
Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection
Intensive Care Medicine, Vol. 37, Núm. 2, pp. 272-283